Medical

  Engineers and physicians at Duke University have developed a handheld device capable of capturing images of a retina with cellular resolution. The probe will allow researchers to gather detailed structural information about the eyes of infants and toddlers for the first time.

University of Wisconsin-Madison Alzheimer’s researchers have identified a scientific approach that may help predict which older adults are more likely to develop cognitive symptoms of Alzheimer’s disease well before the onset of dementia. This approach – which statistically analyses a panel of biomarkers – could help identify people most likely to benefit from drugs or other interventions to slow the progress of the d...

  GSK announced an agreement with Verily Life Sciences LLC (formerly Google Life Sciences), an Alphabet company, to form Galvani Bioelectronics to enable the research, development and commercialisation of bioelectronic medicines. GSK will hold a 55% equity interest in the new jointly owned company and Verily will hold 45%.

Surface Plasmon Resonance (SPR) devices are the benchmark in optical sensing. They are used for detecting biomarkers of disease, discovering drugs, analysing chemicals, ensuring food quality and safety, and detecting pollutants in our environment. SPR devices can detect molecules within a few hundred nanometres of their metal surfaces.

Scientists in Singapore have made a big leap on research on the 'mini-brain'. These advanced mini versions of the human midbrain will help researchers develop treatments and conduct other studies into Parkinson's Disease[1] (PD) and ageing-related brain diseases. These mini midbrain versions are 3D miniature tissues that are grown in the laboratory and they have certain properties of specific parts of the human brain. 

In their mission to design biomaterials that promote tissue regeneration, Drexel University researchers have identified how inflammation, when precisely controlled, is crucial to bone repair. Their findings, published in the Journal of the Royal Society Interface, show that a new type of ceramic scaffold causes inflammatory cells to behave in a way that is more regenerative than scaffolds that are currently used clinically.

The Valens Colligo System On Module (SOM) – a turnkey, pre-certified HDBaseT 2.0 solution designed to minimise the cost, time and effort of bringing HDBaseT to market is available from L2Tek. With board design issues already managed, the Colligo SOM devices allow developers to focus attention on the interface connections needed to ensure a successful and timely product rollout.

A combined team of researchers from Boston University and Beth Israel Deaconess Medical Center, also in Boston, has published a paper in the journal Angewandte Chemie describing a type of hydrogel they have developed for use as a bandage for burn patients—one that can be removed by applying another liquid rather than by cutting, as is done with conventional bandages.

Researchers at CNRS, INSERM, Aix-Marseille University and AP-HM have just created a virtual brain that can reconstitute the brain of a person affected by epilepsy for the first time. From this work we understand better how the disease works and can also better prepare for surgery. These results are published in Neuroimage. Worldwide, one percent of the population suffers from epilepsy.

A portable production system, designed to manufacture a range of biopharmaceuticals on demand, has been developed by researchers at MIT, with funding from the Defense Advanced Research Projects Agency (DARPA). In a paper published in the journal Nature Communications, the researchers demonstrate that the system can be used to produce a single dose of treatment from a compact device containing a small droplet of cells in a liquid.